NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, has received approval from the Israeli …
Celsus Therapeutics PLC Announces Details of Annual General Meeting of Shareholders
NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, announced today that the annual general …
Celsus Therapeutics Plc Announces Formation of New Dermatology Scientific Advisory Board
NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, announced today the formation of a new …
Celsus Therapeutics Plc to Present at the 13th Annual Needham Healthcare Conference
NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, announced today that Dr. Gur Roshwalb, Chief …
Celsus Therapeutics Provides Year End 2013 Financial Results and Corporate Highlights
NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, today announced its financial results and …
